hera Guiding Precision Therapies for Seizures By www.medindia.net Published On :: Alterations in the SCN2A gene influence the age of seizure onset and the severity of neurological impairments in affected children, aiding in the identification Full Article
hera Gene Therapy Restores Vision for Patients Born Blind By www.medindia.net Published On :: Patients born with genetic medlinkblindness/medlink experienced significant visual improvements after a single treatment with gene therapy developed Full Article
hera Monoclonal Antibodies: Revolutionizing Drug Therapies By www.medindia.net Published On :: Monoclonal antibodies (mAbs) are special proteins used to help prevent, detect, and treat a wide range of diseases, both infectious and non-infectious. Full Article
hera Fat-Derived Cellular Therapy: A New Hope for Diabetes Treatment By www.medindia.net Published On :: Fat-Derived cellular therapy offers a promising new approach for diabetes, using cells from body fat to improve insulin function and potentially reverse the disease. Full Article
hera Truth About Using Shockwave Therapy for Erectile Dysfunction By www.medindia.net Published On :: Erectile dysfunction (ED) is a condition that affects millions of men throughout the world. It can occur at any age and have an impact on the quality of someone's life. Full Article
hera Remodelling Signal Pathways in Prostate Cancer - A New Therapeutic Target! By www.medindia.net Published On :: medlinkCancer/medlink-causing mutations in prostate cancer hyperactivate PI3K signaling, leading to cancer cell growth. PLEKHS1, a largely unknown Full Article
hera Combination Therapy Holds Promise for Advanced Prostate Cancer Treatment By www.medindia.net Published On :: Decitabine, a medlinkprostate cancer/medlink drug, that inhibits DNA methylation, effectively cuts tumor growth in prostate cancer with neuroendocrine features or loss of the gene RB1. Full Article
hera How Oncolytic Virotherapy Helped Beat Breast Cancer By www.medindia.net Published On :: Discover how Beata Halassy, a virologist, used oncolytic virotherapy to treat her breast cancer successfully. Full Article
hera Actress Samantha Underwent Hyperbaric Oxygen Therapy for Myositis By www.medindia.net Published On :: bHighlights:/bul class="group-list punch-points" liActress Samantha Ruth Prabhu open about her health struggles on social media in late 2022/li liShe Full Article
hera Princess of Wales Begins Chemotherapy in Cancer Battle By www.medindia.net Published On :: Catherine, the Princess of Wales, has disclosed her cancer diagnosis and is currently undergoing medlinkchemotherapy/medlink (!--ref1--) treatment. Full Article
hera Combination Therapy Reduces Blood Pressure With Ibrutinib Treatment By www.medindia.net Published On :: Combining two or more blood pressure medications can markedly medlinklower blood pressure/medlink in patients on ibrutinib. (!--ref1--) Targeted Full Article
hera Study Reveals Why HIV Remains in Human Tissue Even After Antiretroviral Therapy By www.medindia.net Published On :: A new study conducted by researchers reveals a possible answer to the mystery of why infected people can't get rid of HIV altogether. In HIV patients, Full Article
hera Promising Tuberculosis Therapy for HIV-positive Patients By www.medindia.net Published On :: A promising new therapy for medlinktuberculosis/medlink (TB) has been shown to be compatible with combined antiretroviral therapy (cART), stated research Full Article
hera Long-Term Relief: Low-dose Antiviral Therapy Eases Eye Disease and Shingles Pain By www.medindia.net Published On :: Long-term, low-dose antiviral treatment lowers the risk of vision-damaging inflammation, infection, and pain from shingles affecting the eye, according Full Article
hera Hospira Unveils TheraDoc Anticoagulation Assistant(TM) Knowledge Module to Help Hospitals Comply With Joint Commission Patient Safety Goal By www.medindia.com Published On :: Hospira Unveils TheraDoc Anticoagulation Assistant(TM) Knowledge Module to Help Hospitals Comply With Joint Commission P Full Article
hera Amicus Therapeutics Announces First Quarter 2010 Financial Results and Product Pipeline Advancements By www.medindia.com Published On :: Amicus Therapeutics Announces First Quarter 2010 Financial Results and Product Pipeline Advancements Full Article
hera Anthera Issues First Quarter 2010 Financial Report By www.medindia.com Published On :: Anthera Issues First Quarter 2010 Financial Report Full Article
hera Alzheimer's Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology By www.medindia.com Published On :: Alzheimer's Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology Full Article
hera Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference By www.medindia.com Published On :: Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference Full Article
hera New Campaign: Estrogen Therapy I.Q. (ETIQ) Kicks Off to Improve Access to Credible Facts About Menopause and Advances in Estrogen Therapy By www.medindia.com Published On :: New Campaign: Estrogen Therapy I.Q. (ETIQ) Kicks Off to Improve Access to Credible Facts About Menopause and Advances in Full Article
hera Halozyme Therapeutics Reports First Quarter 2010 Financial Results By www.medindia.com Published On :: Halozyme Therapeutics Reports First Quarter 2010 Financial Results Full Article
hera Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study By www.medindia.com Published On :: Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study Full Article
hera Artificial Intelligence Revolutionizes the Future of Cancer Therapy By www.medindia.net Published On :: According to health experts, medlinkartificial intelligence/medlink (AI) is advancing cancer treatment, enhancing traditional methods like medlinkchemotherapy/medlink, Full Article
hera AI Breakthrough: Accelerating Effective Antibiotic Therapy for Sepsis By www.medindia.net Published On :: medlinkSepsis/medlink poses a life-threatening infection complication, leading to 1.7 million hospitalizations and 350,000 deaths annually in the U. Full Article
hera Advancing Heart Treatment in India With AI-Driven Therapies By www.medindia.net Published On :: Experts emphasize that Artificial Intelligence (AI) has the potential to transform heart disease treatment in India by enabling early detection and personalized Full Article
hera Gene Therapy Converts Omega-6 to Omega-3 Fatty Acids to Combat Arthritis By www.medindia.net Published On :: medlinkChildhood obesity/medlink, affecting nearly 20% of children and teens, has severe implications for their health, increasing the risk of medlinkarthritis/medlink, Full Article
hera Progress of Plant-made Vaccines and Therapeutics By www.medindia.net Published On :: Advances in technology and manufacturing could boost the uptake of therapeutics derived from plants. Therapeutic proteins such as antibodies, hormones, Full Article
hera Aromatherapy can Reduce Post-surgical Opioid Use by Half: Study By www.medindia.net Published On :: Post-surgical opioid use in hip replacement patients can be reduced by half with aromatherapy, reveals a new study. The new preliminary was study Full Article
hera AstraZeneca Collaborates With Wallenberg for Developing Secretome Therapeutics By www.medindia.net Published On :: London-Based drug firm, AstraZeneca has entered into a new field of developing drugs using proteins secreted by the cells called as "Secretome". It has Full Article
hera California-Based Company to Roll Out World's First Stem Cell Therapy On Parkinson's Disease By www.medindia.net Published On :: A California-based company has received approval for trying out the world's first stem therapy on patients affected with mild to severe Parkinson's disease. Full Article
hera Shire Receives Breakthrough Therapy Designation for Rare Diseases Drugs By www.medindia.net Published On :: US Food and Drug Administration has granted breakthrough therapy designation for two experimental drugs for rare diseases conducted by the biotechnology company Shire. Full Article
hera Using Disease-Modifying Therapy for Alzheimer's Disease Treatment By www.medindia.net Published On :: A novel, disease-modifying therapy or treatment for Alzheimer's disease that may involve a whole blood transfusion effectively reduces amyloid plaque Full Article
hera Basudev Behera & Another vs State Of Odisha .... Opp. Party on 11 November, 2024 By indiankanoon.org Published On :: Heard. 2. At the instance of the petitioner No.2, the F.I.R. in connection with Bari Ramachandrapur P.S. Case No.94 of 2017 corresponding to G.R. Case No.631 of 2017 came to be registered against the petitioner No.1 for the offences punishable under Sections 498(A)/323/325/506/34 of the IPC read with Section 4 of the D.P. Act pending in the Court of learned S.D.J.M., Jajpur. Page 1 of 4 3. The petitioner No.1 is the husband of the petitioner No.2. Their marriage was solemnized in the year 2016. Few days after their marriage, dissention arose in their family for which the petitioner No.2 lodged the F.I.R. being Bari Ramachandrapur P.S. Case No.94 of 2017 for the above alleged offences. Full Article
hera Wissensspeicher der Frühen Neuzeit : Formen und Funktionen [Electronic book] / herausgegeben von Frank Grunert und Anette Syndikus. By encore.st-andrews.ac.uk Published On :: Berlin ; Boston : De Gruyter, [2015] Full Article
hera Lutheran theology : a critical introduction [Electronic book] / Paul R. Hinlicky. By encore.st-andrews.ac.uk Published On :: Eugene, Oregon : Cascade Books, [2020] Full Article
hera Humanitarian intervention in the long nineteenth century : Setting the precedent [Electronic book] / Alexis Heraclides, Ada Dialla. By encore.st-andrews.ac.uk Published On :: Manchester : Manchester University Press, [2017] Full Article
hera Tuning the phototherapeutic activity of Pt(IV) complexes for bladder cancer via modification of trans N-heterocyclic ligands By pubs.rsc.org Published On :: Inorg. Chem. Front., 2024, 11,7898-7909DOI: 10.1039/D4QI01765J, Research Article Open Access   This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Huayun Shi, Guy J. Clarkson, Peter J. SadlerThe photochemotherapeutic activity of diazido Pt(IV) complexes towards bladder cancer, a common cancer with expensive treatment, has been tuned via modification of trans N-heterocyclic ligands, to give a candidate for preclinical development.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera Brachytherapy on-a-chip: a clinically-relevant approach for radiotherapy testing in 3d biology By pubs.rsc.org Published On :: Lab Chip, 2024, 24,2335-2346DOI: 10.1039/D4LC00032C, PaperRodin Chermat, Elena Refet-Mollof, Yuji Kamio, Jean-François Carrier, Philip Wong, Thomas GervaisWe introduce the first brachytherapy-on-chip device for in vitro testing of brachytherapy on naturally hypoxic tumor spheroids, for translational research and drug development.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera Current status of controlled onco-therapies based on metal organic frameworks By pubs.rsc.org Published On :: RSC Adv., 2024, 14,12817-12828DOI: 10.1039/D4RA00375F, Review Article Open Access   This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.Yixuan Yang, Xiaofeng DaiMost MOFs for controllable cancer treatment act as drug delivery vehicle and/or anti-cancer agent. Molecules with anti-cancer roles such as chemotherapies, gases, peptides or nucleic acids can be loaded into MOFs that decompose in cancer cells or in the TME to release its cargoes.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera Construction of glutathione-responsive paclitaxel prodrug nanoparticles for image-guided targeted delivery and breast cancer therapy By pubs.rsc.org Published On :: RSC Adv., 2024, 14,12796-12806DOI: 10.1039/D4RA00610K, Paper Open Access   This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.Weiwei Ma, Qiufeng Zhao, Shilong Zhu, Xinyue Wang, Chuangchuang Zhang, Daming Ma, Na Li, Yanyan YinHA-coated redox sensitive visualized nano-prodrug HA/TPE-CS-SS-PTX were exploited in order to highly efficient treatment of cancer and real-time monitoring of drug localization.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera Self-supplying Cu2+ and H2O2 synergistically enhancing disulfiram-mediated melanoma chemotherapy By pubs.rsc.org Published On :: RSC Adv., 2024, 14,13180-13189DOI: 10.1039/D4RA01075B, Paper Open Access   This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.Yingqian Gao, Xiaojun Cai, Weijuan Zou, Xiuzhen Tang, Lixian Jiang, Junnian Hao, Yuanyi Zheng, Xinhua Ye, Tao Ying, Ao LiDisulfiram (DSF) can target and kill cancer cells by disrupting cellular degradation of extruded proteins and has therefore received particular attention for its tumor chemotherapeutic potential.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera Decellularization of caprine forestomach rumen tissue modified with silver nanowires as an antibacterial skin substitute scaffold in wound care therapeutics By pubs.rsc.org Published On :: J. Mater. Chem. B, 2024, Advance ArticleDOI: 10.1039/D4TB01560F, PaperAthmana P. A., Asna Jaleel K. I., Sinduja Malarkodi Elangovan, Riza Paul, Naveen Subbaiyan, Parthiban Shanmugam, Gopal Shankar KrishnakumarCaprine forestomach native collagen (CFNC) modified with silver nanowires (AgNWs) as a new class of biomimetic xenograft for skin regeneration with strong antimicrobial properties.To cite this article before page numbers are assigned, use the DOI form of citation above.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera Expression of concern: Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer By pubs.rsc.org Published On :: J. Mater. Chem. B, 2024, Advance ArticleDOI: 10.1039/D4TB90175D, Expression of Concern Open Access   This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Lei Bai, Wenhui Yi, Taiyang Sun, Yilong Tian, Ping Zhang, Jinhai Si, Xun Hou, Jin HouTo cite this article before page numbers are assigned, use the DOI form of citation above.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera Efficient bionic nanozyme based on AuPt NPs@ZIF-90 used for cyclic catalysis multimodal tumor therapy By pubs.rsc.org Published On :: J. Mater. Chem. B, 2024, Advance ArticleDOI: 10.1039/D4TB01987C, PaperWan Huang, Song Zhang, Li Luo, Yalong Pan, Lijun Han, Yao YuNovel efficient bionic nanozyme based on AuPt NPs@ZIF-90 used for cyclic catalysis multimodal tumor therapy.To cite this article before page numbers are assigned, use the DOI form of citation above.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera Electronic band structure modulation for sonodynamic therapy By pubs.rsc.org Published On :: J. Mater. Chem. B, 2024, Accepted ManuscriptDOI: 10.1039/D4TB01679C, Review ArticleYafang Shi, Chengzhilin Li, Linquan Li, Qingbin He, Qingyi Zhu, Ziang Xu, Yanzi Liu, Nianlei Zhang, Meng Zhang, Jianwei Jiao, Runxiao ZhengSonodynamic therapy (SDT) is a burgeoning and newfangled therapy modality with great application potential. Sonosensitizers are most essential factors to ensure the effectiveness of SDT. For the past few years,...The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera A dual-functional photosensitizer for mitochondria-targeting photodynamic therapy and synchronous polarity monitoring By pubs.rsc.org Published On :: J. Mater. Chem. B, 2024, 12,11259-11264DOI: 10.1039/D4TB01872A, PaperLiu Yang, Shenglong Gan, Jie Zhang, Yin Jiang, Qingxin Chen, Hongyan SunA dual-functional photosensitizer was developed, exhibiting potent phototoxicity and sensitivity to polarity changes.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera A simple hydrogen peroxide-activatable Bodipy for tumor imaging and type I/II photodynamic therapy By pubs.rsc.org Published On :: J. Mater. Chem. B, 2024, 12,11165-11171DOI: 10.1039/D4TB01650E, PaperFangqing Ge, Yujie Sun, Yu Wang, Dan Yu, Zhijia Wang, Fabiao Yu, Bingran Yu, Hongbing FuA H2O2-activatable Bodipy with simultaneous type I and type II photosensitization was designed for tumor imaging and therapy.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera Chitosan-functionalized nanobubbles for precision oncology: advances in targeted cancer therapeutics By pubs.rsc.org Published On :: J. Mater. Chem. B, 2024, 12,11076-11088DOI: 10.1039/D4TB01930J, Review ArticleVivek Pandey, Tejasvi PandeyThe convergence of nanotechnology and cancer therapeutics has opened new frontiers in the development of advanced drug delivery systems.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera Breakthrough in cancer therapy: lutetium texaphyrin–celecoxib conjugate for immune and photodynamic treatment By pubs.rsc.org Published On :: J. Mater. Chem. B, 2024, Advance ArticleDOI: 10.1039/D4TB02019G, Highlight Open Access   This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Qihang Ding, Yue Wang, Pengfei Zhang, Ling MeiKim et al. present a small-molecule photosensitizer, LuCXB, which combines a COX-2 inhibitor (celecoxib) with a near-infrared lutetium texaphyrin photocatalyst and was loaded CD133-aptamer functionalized exosome for cancer stem cells targeting.To cite this article before page numbers are assigned, use the DOI form of citation above.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article
hera A guanidiniocarbonyl-pyrrole functionalized cucurbit[7]uril derivative as a cytomembrane disruptor for synergistic antibacterial therapy By pubs.rsc.org Published On :: J. Mater. Chem. B, 2024, 12,11105-11109DOI: 10.1039/D4TB01840K, CommunicationRuixue Han, Kehan Du, Shengke Li, Minzan Zuo, Ponmani Jeyakkumar, Hao Jiang, Leyong Wang, Xiao-Yu HuA guanidiniocarbonyl-pyrrole functionalized cucurbit[7]uril derivative as a cytomembrane disruptor has been successfully constructed for synergistic antibacterial therapy.The content of this RSS Feed (c) The Royal Society of Chemistry Full Article